Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Patent Selections
Volume: 11 Issue: 1
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Patent Selections, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2017; 11 (1) . https://dx.doi.org/10.2174/187221481101180606075324
DOI https://dx.doi.org/10.2174/187221481101180606075324 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
18
2
Related Articles
-
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical Design Insights into the Platelet Releasate
Current Pharmaceutical Design Graphical Abstracts
Current Organic Chemistry Development of Novel Glitazones as Antidiabetic Agents: Molecular Design, Synthesis, Evaluation of Glucose Uptake Activity and SAR Studies
Letters in Drug Design & Discovery Cyclosporin A: A Therapeutic Strategy in Allergic Diseases
Letters in Drug Design & Discovery Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters Rapid Determination of Acarbose in Tablets by 1H NMR Spectroscopy
Current Pharmaceutical Analysis Synthesis of a Novel Series of 8-HETE Analogs and their Biological Evaluation Towards the PPAR Nuclear Receptors
Letters in Drug Design & Discovery Bridging Innate Immunity and Myocardial Ischemia/Reperfusion Injury: The Search for Therapeutic Targets
Current Pharmaceutical Design Medicinal Plants in Neurodegenerative Diseases: Perspective of Traditional Persian Medicine
Current Drug Metabolism Low Osteopontin N-Terminal Fragment and Carotid Plaque Stability Associated with Statin or Antiplatelet Therapy
Current Vascular Pharmacology Risk and Benefit Profile of Dulaglutide in Established Therapeutic Indication
Current Drug Safety The Therapeutic Potential of Differentiated Lung Cells from Embryonic Stem Cells in Lung Diseases
Current Stem Cell Research & Therapy MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases
Current Pharmaceutical Design Quercetin Actions on Lipid Profiles in Overweight and Obese Individuals: A Systematic Review and Meta-Analysis
Current Pharmaceutical Design Modified cAMP Derivatives: Powerful Tools in Heart Research
Current Medicinal Chemistry Tumor-Induced Metabolism and T Cells Located in Tumor Environment
Current Cancer Drug Targets Editorial: Inflammasome Complex in Health and Disease: New Pharmacological Perspectives
Current Drug Targets New Lipid Modulating Drugs: The Role of Microsomal Transport Protein Inhibitors
Current Pharmaceutical Design Impaired Myocardial MIF/AMPK Activation Aggravates Myocardial Ischemia Reperfusion Injury in High-Fat Diet-Induced Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets